Remap Consulting provides an integrated approach to pharmaceutical pricing & market access solutions.
We are a specialist pricing, reimbursement and market access consultancy offering an integrated, evidence-based approach to optimising market access. Our strength lies in our ability to understand the market access challenges from your perspective and to develop payer-focused solutions tailored to your business needs.
This is a FREE LISTING on PMHUB
Below are full profiles from other companies in related areas
We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by strategically aligning promotion, medical education and PR across the product…
Advertising, Branding, Clinical Research, Conference/meetings/events, Creative and design, Digital communications, Management consultancies, Market access, Market research, Marketing consultancies, Medical communications, Medical education, Patient support and adherence, Public relations, Regulatory affairs
MDNT is a native Digital and Omnichannel agency focused solely on the healthcare, pharma, and life science industries. We’re highly experienced, no nonesense, and very good at what we do.
Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national and international reach. As we understand the healthcare market and…
OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health outcomes and patient wellbeing.
Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make a positive contribution to patient care. Real world experience of…
Company Details
Latest Content from PMHub
Videos and Podcasts | July 21, 2022 | Impetus Digital
Richard Houlihan, CEO of EirMed, explores topics related to EUDAMED, the European Databank for Medical Devices, including the key pain points and concerns MedTech companies encounter related to EUDAMED and...
Press Releases | July 21, 2022 | Genesis Research Group
International Real-World Evidence (RWE) and Health Economics and Outcomes Research (HEOR) organization Genesis Research is delighted to announce an exciting new partnership with Clinical Outcomes Assessment (COA) specialist Clinical Outcomes...
Press Releases | July 20, 2022 | Cuttsy + Cuttsy
Louise Jones, Sustainability Officer at Cuttsy+Cuttsy celebrates their new silver sustainability rating
Press Releases | July 19, 2022 | Nucleus Global
Triple success across Inizio at the leading European Healthcare Communications Awards
Press Releases | July 18, 2022 | Onyx Health
Onyx Health has expanded its digital content team with the appointments of Hope Johnston as Digital Content Manager and Jordan Carr as Social Media Executive.
White Papers and Resources | July 18, 2022 | Page & Page Health
We live in an era of robust and thorough evidence and there is no place for historical biases and that requires everyone involved to look beyond women’s reproductive cycle and...
Videos and Podcasts | July 14, 2022 | Impetus Digital
Brian Canestraro, General Manager at Intercept Pharmaceuticals, discusses leadership lessons and tips to the impact of the COVID-19 pandemic on the way that Pharma conducts clinical trials and interacts with...
White Papers and Resources | July 14, 2022 | Havas Life London
As part of the development of content and communication strategies in healthcare, we mine for insights into audience behaviours – identifying what HCPs or patients think and how they act;...
Press Releases | July 14, 2022 | Medscape Education
The world of medical device technology is constantly evolving. From wearable devices to diagnostic technology, clinicians have more options than ever for monitoring and assessing their patients' health. The accessibility...
White Papers and Resources | July 14, 2022 | Inizio
Download our latest infographic, which offers an introduction to the real-world patient insights collected by our Therapy Watch Lupus study.